Join the club for FREE to access the whole archive and other member benefits.

Digital Modeling

Virtual 3D models of the body and individual organs will allow us to test drugs and procedures faster than ever before with no harm to patients or animals.

Clinical trials (i.e. testing a drug in humans) can take years to perform - going through phase 1 (checking for safety), phase 2 (checking for efficacy and side-effects) and phase 3 (monitoring adverse reactions). Less than one in ten successfully make it to market. That's a lot of wasted time and effort.

Digital modelling allows testing from a cellular level to whole body interactions to take place in silico - in software. As the digital models improve, and the speed of computers continue to increase, rather than taking months to perform a phase 1 trial this may be carried out in a few days on a supercomputer. Even if not 100% accurate to start with, it should at least increase the success rate of drug development.


Click on resource name for more details.


Patient-specific heart simulation for optimal therapy and In silico evaluation of cardiotoxicity and drug discovery company

More Digital Modeling resources

Digital Modeling Blog Posts

Virtual Bodies are Accelerating Research and Diagnostics

Virtual Bodies are Accelerating Research and Diagnostics

A quick summary of projects trying to recreate cells, tissues and organs in silico

Recent News

Revolutionary bio-inspired molecules accelerate bone healing: a breakthrough for regenerative medicine

TU Dresden (University of Technology) - 28-Apr-2023

Novel molecules enhance bone regeneration in mice by 50%, paving the way for treatments for bone fractures and related conditions


World's first 3D female anatomy model is available in the Complete Anatomy app

Healthline - 09-Feb-2022

Female model allows health professionals have a better perspective on women's health


Technology to create virtual tumours and treat them with AI-designed nanoparticles

Nano Magazine - 22-Sep-2021

Virtual cancer tumours can be grown and we can design personalised nanoparticles to treat them


EVONANO platform makes virtual tumour growth and drug design possible

University of Bristol - 22-Sep-2021

AI-powered software can be an alternative for expensive and extensive lab work


Study on the accuracy of in-silico trials as compared to traditional trials

Medgadget - 24-Jun-2021

Virtual clinical trial can reduce the cost and time required while reducing risk

More Digital Modeling News